StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a report published on Sunday. The firm issued a sell rating on the biopharmaceutical company’s stock.
Aeterna Zentaris Stock Performance
NASDAQ AEZS opened at $3.80 on Friday. The firm has a market cap of $6.81 million, a PE ratio of -0.25 and a beta of 1.55. Aeterna Zentaris has a one year low of $3.96 and a one year high of $12.00. The firm’s fifty day moving average is $4.90 and its two-hundred day moving average is $6.50.
About Aeterna Zentaris
Featured Stories
- Five stocks we like better than Aeterna Zentaris
- How to Invest in Blue Chip Stocks
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Stock Dividend Cuts Happen Are You Ready?
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Aeterna Zentaris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeterna Zentaris and related companies with MarketBeat.com's FREE daily email newsletter.